Skip to main content
. 2021 Jul 23;9(7):e002446. doi: 10.1136/jitc-2021-002446

Figure 2.

Figure 2

(A) Best percentage change in target lesion size from baseline and (B) percentage change in tumor burden over time. *Indicates that the patient is still on treatment. H, high PD-L1 expression; L, low PD-L1 expression; NE, not evaluable; Neg, no PD-L1 expression; Unk, unknown PD-L1 expression.